Cellectis Net Income From Continuing Ops from 2010 to 2024

CLLS Stock  USD 1.87  0.01  0.54%   
Cellectis Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss will likely drop to about -122.7 M in 2024. From the period from 2010 to 2024, Cellectis Net Loss quarterly data regression had r-value of (0.88) and coefficient of variation of (63.27). View All Fundamentals
 
Net Loss  
First Reported
2012-12-31
Previous Quarter
-25.3 M
Current Value
-23.1 M
Quarterly Volatility
23.4 M
 
Yuan Drop
 
Covid
Check Cellectis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellectis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.4 M, Interest Expense of 6.7 M or Selling General Administrative of 30.4 M, as well as many indicators such as Price To Sales Ratio of 223, Dividend Yield of 0.0 or PTB Ratio of 3.61. Cellectis financial statements analysis is a perfect complement when working with Cellectis Valuation or Volatility modules.
  
Check out the analysis of Cellectis Correlation against competitors.

Latest Cellectis' Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Cellectis SA over the last few years. It is Cellectis' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellectis' overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Cellectis Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(70,669,661)
Geometric Mean49,371,970
Coefficient Of Variation(63.27)
Mean Deviation40,354,461
Median(88,331,000)
Standard Deviation44,712,195
Sample Variance1999.2T
Range127M
R-Value(0.88)
Mean Square Error475.8T
R-Squared0.78
Significance0.000013
Slope(8,824,222)
Total Sum of Squares27988.5T

Cellectis Net Income From Continuing Ops History

2024-122.7 M
2023-116.8 M
2022-98.7 M
2021-125.1 M
2020-97.5 M
2019-115.2 M
2018-88.3 M

About Cellectis Financial Statements

Cellectis shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Cellectis investors may analyze each financial statement separately, they are all interrelated. The changes in Cellectis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellectis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-116.8 M-122.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.